Protiva Sues Inex, Sirna in Bid to Establish Ownership of siRNA Delivery Technology

One suit claims that Inex -- Protiva s one-time parent -- inappropriately made statements indicating that Protiva did not fully own and control its lipid-based delivery technology. The second one claims that Sirna agreed to partner with Protiva on applying its delivery technology to RNAi, all the while planning to develop its own system based on Protiva s technology. Subscribers: click headline for more

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.